SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133970
Filing Date
2022-04-29
Accepted
2022-04-29 16:32:40
Documents
3
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d349928ddef14a.htm DEF 14A 260160
2 GRAPHIC g349928dsp028.jpg GRAPHIC 180990
3 GRAPHIC g349928dsp029.jpg GRAPHIC 103633
  Complete submission text file 0001193125-22-133970.txt   653566
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40908 | Film No.: 22876227
SIC: 2836 Biological Products, (No Diagnostic Substances)